KENZIE SCHEIDT: Open Payments
NPI 1992099824 · SPRINGFIELD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 18 payments from 7 companies in 2025. Trend: 2023 $819 · 2024 $689 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $233 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Amgen Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: AVEIR, ELIQUIS, LEQVIO, REPATHA, Kerendia, Wegovy.
Industry payments across OR — which companies pay providers there.
